Spots Global Cancer Trial Database for Circulating Tumoral DNA in Choroidal Melanoma (ctDNA MU)
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Circulating Tumoral DNA in Choroidal Melanoma (ctDNA MU)
Official Title: Study of Circulating Tumoral DNA Evolution in Plasma in Choroidal Melanoma
Study ID: NCT02875652
Conditions
Interventions
Study Description
Brief Summary: Quantification and follow-up during 3 years of circulating tumoral DNA in patients with choroidal melanoma
Detailed Description: This study is a prospective, open-labelled, monocentric trial. The aim is to observe, in patient with choroidal melanoma (any stage of the disease), the prevalence of the circulating tumor DNA at the diagnostic and its evolution during 3 years. The patient will have a blood sample at the following times : * T0: before treatment of the primary tumor. * T1: 1 months after the end of the local treatment. * T2: at 7 months. * Tn: every 6 months up to 3 years.
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Institut Curie, Paris, , France
Contact Details
Name: Laurence Desjardins, MD
Affiliation: Institut Curie
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
